MicroTech Medical (Hangzhou) Co., Ltd. (02235) published its monthly return for equity securities as of January 31, 2026. The total authorized share capital remained at RMB 421,078,000, comprising domestic shares, unlisted foreign shares, and H shares.

The issued H shares (excluding treasury shares) reached 165,788,042 at the end of January 2026, reflecting a decrease of 215,900 shares compared to the previous month. The company repurchased 215,900 H shares during January, leading to an increase in treasury shares from 3,171,900 to 3,387,800. The repurchased shares have been retained as treasury shares. The domestic shares and unlisted foreign shares remained unchanged at 208,205,474 and 43,696,684 shares, respectively.

According to the report, the company again confirmed compliance with the applicable public float requirement for its H shares. No other share options, warrants, or convertibles were outstanding, and there were no new issues beyond the share repurchases recorded in January.